Megna Michael R Insider Trading -- Recent SEC Form 4 Transactions
Megna Michael R (CIK 1464583) reported 48 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Buy KNSA (11,280 shares), Sell KNSA (11,280 shares), Sell KNSA (5,350 shares), Buy KNSA (3,932 shares), Buy KNSA (7,209 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 11,280 | $200,333 |
| 2026-11-12 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 11,280 | $1.1M |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 5,350 | $522,909 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 3,932 | $43,645 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 7,209 | $86,292 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 4,065 | $72,194 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 6,030 | $553,976 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 6,831 | $633,712 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 9,508 | $895,654 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 3,705 | $351,456 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 3,145 | $302,172 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 1,691 | $164,213 |
| 2026-11-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 4,689 | $50,454 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 279 | $9,346 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 3,932 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 2,558 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 2,362 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 2,644 | $0 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 5,531 | $438,498 |
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 4,600 | $369,380 |
| 2026-04-13 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 6,625 | $309,321 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 3,932 | $3,932 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 1,666 | $81,534 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 372 | $8,988 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 7,564 | $0 |
Source: SEC Form 4 filings · as of 2026-11-12